1. Terry TL. Fibroblastic overgrowth of persistent
tunica vasculosum lentis in infants born prematurely, II: report
of cases, clinical aspects. Trans Am Ophthalmol Soc. 1942;40;262-284.
2. Goldberg MF. Persistent fetal vasculature (PFV): an integrated
interpretation of signs and symptoms associated with persistent
hyperplastic primary vitreous (PHPV): LIV Edward Jackson Memorial
Lecture.
Am J Ophthalmol. 1997; 124:587-626.
[PubMed: 9372715]
3. Reese AB, Blodi FC, Locke JC. The pathology of early retrolental
fibroplasia. With an analysis of the histology findings in the eyes
of newborn and stillborn infants. Am J Ophthalmol.
1952; 35;1407-1426.
4. Kinsey VE, Hemphill FM, for the Cooperative Study of Retrolental
Fibroplasia. Etiology of retrolental fibroplasia and preliminary
report of cooperative study of retrolental fibroplasia.
Trans
Am Acad Ophthalmol. 1955;59:15.
[PubMed: 14359370]
5. Schaffer DB, Palmer EA, Plotsky DF, et al, on behalf of the
Cryotherapy for Retinopathy of Prematurity Cooperative Group. Prognostic
factors in the natural course of retinopathy of prematurity.
Ophthalmology.
1993;100:230-237.
[PubMed: 8437832]
6. Saunders RA, Donahue MD, Christmann LM, et al, for the Cryotherapy
for Retinopathy of Prematurity Cooperative. Racial variation in
retinopathy of prematurity.
Arch Ophthalmol. 1997;115:604-608.
[PubMed: 9152127]
7. Palmer EA, Flynn JT, Hardy RJ, et al. Incidence and early
course of retinopathy of prematurity.
Ophthalmology.
1991;98:1628-1640.
[PubMed: 1800923]
8. Early Treatment for Retinopathy of Prematurity Cooperative
Group. Revised indications for the treatment of retinopathy of prematurity:
results of the early treatment for retinopathy of prematurity randomized
trial. Arch Ophthalmol. 2003; 121:1684-1694.
9. Early Treatment for Retinopathy of Prematurity Cooperative
Group. The incidence and course of retinopathy of prematurity: findings
from the Early Treatment for Retinopathy of Prematurity Study. Pediatrics. 2005;116:15-23.
11. Sonmez K, Drenser K, et al. Vitreous levels of stromal cell-derived
factor 1 and vascular endothelial growth factor in patients with
retinopathy of prematurity. Ophthalmology. In press.
12. Cryotherapy for Retinopathy of Prematurity Cooperative.
Multicenter trial of cryotherapy for retinopathy of prematurity:
three-month outcome. Arch Ophthalmol. 1990;108:195-204.
13. Quinn GE, Dobson V, Biglan A, Evans J, Plotsky D, Hardy
RJ. Correlation of retinopathy of prematurity in fellow eyes in
the CRYO-ROP Study.
Arch Ophthalmol. 1995;113:469-473.
[PubMed: 7710397]
14. An international classification of retinopathy of
prematurity. Pediatrics. 1984;74:127-133.
15. An International Committee for the Classification of Retinopathy
of Prematurity. The international classification of retinopathy
of prematurity revisited. Arch Ophthalmol. 2005;
123:991-999.
16. Capone A, Ells AL, Fielder AR, et al. Standard image of
plus disease in retinopathy of prematurity. [Erratum letter
for above citation.] Arch Ophthalmol. 2007;124:1669-1670.
17. Repka MX, Palmer EA, Tung B, on behalf of the Cryotherapy
for Retinopathy of Prematurity Cooperative Group. Involution of
retinopathy of prematurity.
Arch Ophthalmol. 2000;118:645-649.
[PubMed: 10815156]
18. Gilbert WS, Quinn GE, Dobson V, Reynolds J, Hardy RJ, Palmer
EA, on behalf of the Cryotherapy for Retinopathy of Prematurity
Cooperative Group. Partial retinal detachment at 3 months after
threshold retinopathy of prematurity: long term structural and functional
outcome.
Arch Ophthalmol. 1996;114:1085-1091.
[PubMed: 8790093]
19. Cryotherapy for Retinopathy of Prematurity Cooperative Group.
Multicenter trial of cryotherapy for retinopathy of prematurity:
preliminary results. Pediatrics. 1988;81(5):697-706.
20. STOP-ROP Multicenter Study Group. Supplemental therapeutic
oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a
randomized, controlled trial. I: Primary outcomes. Pediatrics.
2000;105(2):295-310.
21. Fierson WM, Flynn J, Good W, Phelps DL, Reynolds J, Saunders
R. Screening examination of premature infants for retinopathy of
prematurity. Pediatrics. 2006;117:572-576.
22. Section on Ophthalmology, American Academy of Pediatrics;
American Academy of Ophthalmology; American Association for Pediatrics
Ophthalmology and Strabismus. [Erratum notice for above
citation: The gestational age criterion should be 30, not 32 weeks,
so it is “30 weeks or less.”] Pediatrics.
2006;118(3):1324.
23. The Laser ROP Study Group. Laser therapy for retinopathy
of prematurity. [Letter to the Editor.] Arch
Ophthalmol. 1994;112:154-156.
24. Cryotherapy for Retinopathy of Prematurity Cooperative Group.
Multicenter trial of cryotherapy for retinopathy of prematurity:
one year outcome—structure and function. Arch Ophthalmol.
1990;108:1408-1416.
25. Repka MX, Tung B, Good WV, et al. Outcome of eyes developing
retinal detachment during the early treatment for ROP Study (ETROP).
Arch
Ophthalmol. 2006;124:24-30.
[PubMed: 16401781]
26. Quinn GE, Dobson V, Barr CC, et al, on behalf of the Cryotherapy
for Retinopathy of Prematurity Cooperative Group. Visual acuity
of eyes after vitrectomy for retinopathy of prematurity: follow-up
at 5-1/2 years. Ophthalmology. 1996;103(4):595-600.
27. Reynolds JD, Hardy RJ, Kennedy KA, et al, for the Light
Reduction in Retinopathy of Prematurity (LIGHT-ROP) Cooperative
Group. Lack of efficacy of light reduction in preventing retinopathy
of prematurity.
N Engl J Med. 1998; 338:1572-1576.
[PubMed: 9603794]
28. Chow LC, Wright KW, Sola A, CSMC Oxygen Administration Study
Group. Can changes in clinical practice decrease the incidence of
severe retinopathy of prematurity in very low birth weight infants? Pediatrics.
2003;111(2):339-345.